A detailed history of Israel Englander (Millennium Management LLC) transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 2,031,745 shares of STRO stock, worth $5.42 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,031,745
Previous 4,361,893 53.42%
Holding current value
$5.42 Million
Previous $12.8 Million 45.0%
% of portfolio
0.0%
Previous 0.01%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.88 - $5.01 $6.71 Million - $11.7 Million
-2,330,148 Reduced 53.42%
2,031,745 $7.03 Million
Q2 2024

Aug 14, 2024

SELL
$2.92 - $5.33 $1.09 Million - $1.99 Million
-374,070 Reduced 7.9%
4,361,893 $12.8 Million
Q1 2024

May 15, 2024

BUY
$3.27 - $5.65 $10.5 Million - $18.1 Million
3,200,094 Added 208.36%
4,735,963 $26.8 Million
Q4 2023

Feb 14, 2024

BUY
$2.07 - $4.54 $66,809 - $146,528
32,275 Added 2.15%
1,535,869 $6.59 Million
Q2 2023

Aug 14, 2023

BUY
$4.25 - $5.88 $2.6 Million - $3.6 Million
611,978 Added 68.64%
1,503,594 $6.99 Million
Q1 2023

May 15, 2023

SELL
$4.48 - $8.45 $2.14 Million - $4.03 Million
-477,405 Reduced 34.87%
891,616 $4.12 Million
Q4 2022

Feb 14, 2023

SELL
$5.41 - $8.08 $6.32 Million - $9.44 Million
-1,168,049 Reduced 46.04%
1,369,021 $11.1 Million
Q3 2022

Nov 14, 2022

BUY
$5.17 - $7.11 $1.19 Million - $1.64 Million
230,278 Added 9.98%
2,537,070 $14.1 Million
Q2 2022

Aug 15, 2022

BUY
$3.41 - $8.95 $6.7 Million - $17.6 Million
1,964,661 Added 574.24%
2,306,792 $12 Million
Q1 2022

May 16, 2022

BUY
$7.78 - $15.31 $1.53 Million - $3.01 Million
196,496 Added 134.92%
342,131 $2.81 Million
Q4 2021

Feb 14, 2022

SELL
$14.25 - $23.53 $982,509 - $1.62 Million
-68,948 Reduced 32.13%
145,635 $2.17 Million
Q3 2021

Nov 15, 2021

SELL
$16.88 - $22.38 $4.45 Million - $5.9 Million
-263,537 Reduced 55.12%
214,583 $4.05 Million
Q2 2021

Aug 16, 2021

SELL
$18.03 - $23.82 $1.42 Million - $1.87 Million
-78,679 Reduced 14.13%
478,120 $8.89 Million
Q1 2021

May 17, 2021

BUY
$20.29 - $27.54 $5.83 Million - $7.91 Million
287,315 Added 106.62%
556,799 $12.7 Million
Q4 2020

Feb 16, 2021

SELL
$10.16 - $23.98 $505,256 - $1.19 Million
-49,730 Reduced 15.58%
269,484 $5.85 Million
Q3 2020

Nov 16, 2020

BUY
$7.44 - $13.15 $1 Million - $1.78 Million
135,067 Added 73.35%
319,214 $3.21 Million
Q2 2020

Aug 14, 2020

BUY
$7.24 - $11.05 $1.14 Million - $1.74 Million
157,672 Added 595.55%
184,147 $1.43 Million
Q1 2020

May 14, 2020

SELL
$6.19 - $12.16 $42,265 - $83,028
-6,828 Reduced 20.5%
26,475 $270,000
Q4 2019

Feb 14, 2020

BUY
$8.15 - $11.39 $59,217 - $82,759
7,266 Added 27.91%
33,303 $366,000
Q3 2019

Nov 14, 2019

BUY
$7.91 - $11.76 $58,787 - $87,400
7,432 Added 39.95%
26,037 $236,000
Q2 2019

Aug 15, 2019

SELL
$9.69 - $12.23 $184,642 - $233,042
-19,055 Reduced 50.6%
18,605 $212,000
Q1 2019

May 14, 2019

BUY
$8.8 - $11.87 $331,408 - $447,024
37,660 New
37,660 $429,000
Q4 2018

Feb 14, 2019

SELL
$8.69 - $14.85 $666,192 - $1.14 Million
-76,662 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$15.0 - $15.2 $1.15 Million - $1.17 Million
76,662 New
76,662 $1.15 Million

Others Institutions Holding STRO

About SUTRO BIOPHARMA, INC.


  • Ticker STRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,161,500
  • Market Cap $139M
  • Description
  • Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...
More about STRO
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.